These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37884214)

  • 1. Microneedle-mediated transdermal delivery of N-acetyl cysteine as a potential antidote for lewisite injury.
    Kshirsagar S; Dandekar A; Srivastava RK; Khan J; Muzaffar S; Athar M; Banga AK
    Int J Pharm; 2023 Nov; 647():123547. PubMed ID: 37884214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Transdermal Delivery of N-Acetylcysteine and 4-Phenylbutyric Acid for Potential Use as Antidotes to Lewisite.
    Dandekar AA; Vora D; Yeh JS; Srivastava RK; Athar M; Banga AK
    AAPS PharmSciTech; 2023 Feb; 24(3):71. PubMed ID: 36828949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
    Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
    Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis.
    Kale M; Kipping T; Banga AK
    Int J Pharm; 2020 Nov; 589():119853. PubMed ID: 32898633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle Mediated Iontophoretic Delivery of Tofacitinib Citrate.
    Dandekar AA; Garimella HT; German CL; Banga AK
    Pharm Res; 2023 Mar; 40(3):735-747. PubMed ID: 35174431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 4-phenylbutyric acid microsponge gel formulations for the treatment of lewisite-mediated skin injury.
    Kshirsagar SM; Viswaroopan N; Ghosh M; Junaid MSA; Haque S; Khan J; Muzaffar S; Srivastava RK; Athar M; Banga AK
    Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38802678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle-mediated transdermal delivery of naloxone hydrochloride for treatment of opioid overdose.
    Puri A; Frempong D; Mishra D; Dogra P
    Int J Pharm; 2021 Jul; 604():120739. PubMed ID: 34048932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism Underlying Pathogenesis of Lewisite-Induced Cutaneous Blistering and Inflammation: Chemical Chaperones as Potential Novel Antidotes.
    Li C; Srivastava RK; Weng Z; Croutch CR; Agarwal A; Elmets CA; Afaq F; Athar M
    Am J Pathol; 2016 Oct; 186(10):2637-49. PubMed ID: 27528504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in polymer microneedle for transdermal drug delivery.
    Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
    Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Novel Self-Dissolving Microneedle-Assisted Percutaneous Delivery System of Diacerein through Solid Dispersion Gel: Solubility Enhancement, Proof of Anti-inflammatory Activity and Safety.
    Shabbir M; Barkat K; Ashraf MU; Nagra U
    Curr Drug Deliv; 2023; 20(9):1351-1367. PubMed ID: 35770410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
    Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
    Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
    [No Abstract]   [Full Text] [Related]  

  • 13. Fabrication of Polymeric Microneedles using Novel Vacuum Compression Molding Technique for Transdermal Drug Delivery.
    Kshirsagar SM; Kipping T; Banga AK
    Pharm Res; 2022 Dec; 39(12):3301-3315. PubMed ID: 36195823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive and iontophoretic transport of pramipexole dihydrochloride across human skin microchannels created by microneedles in vitro.
    Saepang K; Li SK; Chantasart D
    Int J Pharm; 2021 Nov; 609():121092. PubMed ID: 34530098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
    Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin delivery systems combined with microneedle technology.
    Jin X; Zhu DD; Chen BZ; Ashfaq M; Guo XD
    Adv Drug Deliv Rev; 2018 Mar; 127():119-137. PubMed ID: 29604374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
    Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
    Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microneedles for transdermal drug delivery: a minireview.
    Vandervoort J; Ludwig A
    Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.